Co-Chair: Stephen Strittmatter (Vincent Coates Professor of Neurology, Director, Program in Cellular Neuroscience, Neurodegeneration and Repair,Yale Medical School). The conference represented a wide-ranging exploration of genetic and environmental causes, research on treatment, and the heartbreaking toll this debilitating illness takes on families and caretakers. Among a series of many thought-leaders in neurology and neuroscience, was a keynote from Steven Paul, formerly President of Lilly Research Laboratories, now Director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medical College. A new play, Lil’s 90th, by Darci Picoult, about a family dealing with the father’s rapidly progressing condition, was the artistic centerpiece of the conference.
SCHEDULE OF EVENTS
1:30 – 2:00 pm Registration, Lobby (coffee and refreshments)
2:00 – 5:30 pm Program, Mainstage
2:00 – 2:30 pm (10 min each)
Introductory Remarks
Gordon Edelstein, Artistic Director, Long Wharf Theatre
David Scheer, Event Organizer, President, Scheer & Company, Vice-Chair, Long Wharf Theatre
Robert Alpern, Dean, Yale Medical School
2:30 – 3:30 pm (15 min each)
Session I: Understanding of Alzheimer’s
2:30-2:35: Stephen Strittmatter, moderator
2:35-2:50 David Holtzman, Chairman of Neurology, Washington University,
St. Louis, MO
2:50-3:05 Lennart Mucke, Head, Gladstone Institute of Neurology, Prof. of Neurology, University of California., San Francisco, CA
3:05-3:20 Stephen Strittmatter, Director Yale CNNR, Prof. of Neurology, Yale, New Haven, CT
3:20-3:30 Q+A led by Steve Strittmatter
3:30-3:45 BREAK
3:45 – 5:00 pm
Session II: Yale Research Relevant to Alzheimer’s Disease
3:45-4:45 David Hafler, moderator
Panelists:
Art Horwich, Prof. of Genetics and Pediatrics, Yale, New Haven, CT
Marina Picciotto, Prof. Psychiatry, Yale
Pietro De Camilli, Director Yale CNNR, Prof. of Cell Biology, Yale
Sreeganga Chandra, Asst. Prof. of Neurology, Yale, New Haven, CT
Amy Arnsten, Prof. of Neurobiology, Yale, New Haven, CT
Christopher Van Dyck, Prof. of Psychiatry, Yale, New Haven, CT
4:45-5:00 Q+A with audience, led by David Hafler
5:00-5:15 BREAK
5:15 – 6:30 (15 min each)
Session III: Developing Therapy for Alzheimer’s (chaired by David Scheer)
5:15–5:20 David Scheer, moderator
5:20-5:35 Steven Paul, President, Lilly Research Laboratories
5:35-5:50 Larry Altstiel, Vice President/(CSO) Pfizer
Neuroscience
5:50-6:05 Howard Feldman, Bristol-Myers Squibb, Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience
6:05-6:20 Husseini Manji, Johnson & Johnson, Global Therapeutic Area Head, Neurosciences, Pharmaceutical Research & Development
6:20-6:30 Q+A led by David Scheer
6:30-7:30 Dinner, Mainstage
7:30-9:40 Performance, Lil’s 90th, Stage II
9:45-10:45 Post-Performance Panel
Michael Fuchs, (moderator) former Chairman of HBO, President of Concourse Health Sciences)
Panelists:
Darci Picoult, Lil’s 90th, Playwright
Gordon Edelstein, Artistic Director, Long Wharf Theatre
Eric Ting, Associate Artistic Director, Long Wharf Theatre
Vincent Marchesi, Professor of Pathology and Professor of Cell Biology
Mary Tinetti, Professor of Medicine, Director, Yale Program on Aging
Husseini Manji, Johnson+Johnson